Oligosaccharides
In clinical developmentAlso known as Oligosaccharide.
Recent clinical, regulatory, research and industry developments relating to this drug.
Interactions of human milk oligosaccharides with the immune system.
Influence of Maternal Milk on the Neonatal Intestinal Microbiome.
INFOGEST static in vitro simulation of gastrointestinal food digestion.
Low-Dose Radiation Conditioning Enables CAR T Cells to Mitigate Antigen Escape.
The Clinical Use of Probiotics in the Uremia Patients Under Chronic Peritoneal Dialysis
Profile
Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.
Clinical trials
The current development programme across all trial phases — status mix, phase distribution and the late-stage studies shaping the evidence base.
Late-stage studies
Phase III+ trials still open or recently active — where late-stage evidence is being generated.
Research activity
Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.
Major research themes8
Journals, researchers & institutions
- Cell research1
- Comprehensive reviews in food science and food safety1
- Frontiers in immunology1
- Microbiology and molecular biology reviews : MMBR1
- Molecular therapy : the journal of the American Society of Gene Therapy1
- Nature communications1
- Alminger M1
- Alvito P1
- Ambalavanan A1
- Anand SS1
- Assunção R1
- Azad MB1
- Ballance S1
- Bode L1
- Teagasc Food Research Centre3
- Aarhus University1
- Center for Cell Engineering1
- Chalmers University of Technology1
- Chanchlani Research Centre1
- Complutense University of Madrid1
Related diseases
Regulator-approved indications and conditions co-mentioned with this drug across the research literature. Number shows shared papers.
Related drugs
Drugs sharing diseases, protein targets and literature with this one. Ranked by graph evidence (shared targets + diseases weighted above co-mentions).
Studied across 3 of the same disease areas as Oligosaccharides in the shared literature.
Studied across 3 of the same disease areas as Oligosaccharides in the shared literature.
Studied across 3 of the same disease areas as Oligosaccharides in the shared literature.
Studied across 3 of the same disease areas as Oligosaccharides in the shared literature.
Studied across 2 of the same disease areas as Oligosaccharides in the shared literature.
Studied across the same disease area as Oligosaccharides in the shared literature.
- RxNorm (U.S. National Library of Medicine) — drug identity
- Europe PMC — research literature
- ClinicalTrials.gov — clinical trials